Find your path to Matt
136 people in our graph share verified history with Matt — schools, employers, funds. One of them is your warm intro.
Wilmari SmitunlockedMatt: together at Stellenbosch University (2014–2017)
×9Matt: together at Stellenbosch University
Matt: together at Delin Ventures
Matt: together at Genasys
About
Matt Symes is an investor at Delin Ventures focusing on early-stage healthcare and life sciences companies. He previously served as Director and Head of Strategy & Finance at Adthera Bio, and worked as a consultant at BCG in the PIPE and Global Health practices. Symes is a Fellow of the Actuarial Society of South Africa.
Experience
- Delin VenturesInvestorcurrent2025 — presentLondon, United Kingdom
- Delin VenturesHead of Strategy & Finance - adthera bio (portfolio)2022 — 2025
- Delin VenturesPrincipal2022 — 2023
- Delin VenturesAssociate2021 — 2022
- adthera bioDirectorcurrent2025 — presentLondon, United Kingdom
- adthera bioHead of Strategy & Financecurrent2022 — present
- Boston Consulting Group (BCG)Senior Associate2020 — 2021Johannesburg, South Africa | NYC, New York
- Boston Consulting Group (BCG)Associate2019 — 2020
- Boston Consulting Group (BCG)Junior Associate2018 — 2019
- GenasysFinancial Analyst2017Cape Town, Western Cape, South Africa
- Boston Consulting Group (BCG)Visiting Associate2017City of Johannesburg, Gauteng, South Africa
Skills & more
InvestingVenture CapitalBiotechnologySmall and Medium-Sized Enterprises (SME)FinanceBusiness StrategyFinancial AnalysisStrategic ConsultingFinancial ModelingManagement ConsultingDeal FlowEntrepreneurship
+1 more
LeadershipFrom Matt's professional profile.
Colleagues at Delin Ventures
Alan Barge
Venture Partner at Delin Ventures
Carol Lynch
Advisor at Delin Ventures
Caroline Haegeman
Associate at Delin Ventures
Christopher Spray
Advisor at Delin Ventures
Colin Sims
Partner at Delin Ventures
Igor Linshits
Founder at Delin Ventures
İskender Dirik
Partner at Delin Ventures
Jakub Czarnecki
Financial Controller at Delin Ventures
Frequently asked questions
- Who is Matt Symes?
- Matt Symes is an investor at Delin Ventures focusing on early-stage healthcare and life sciences companies. He previously served as Director and Head of Strategy & Finance at Adthera Bio, and worked as a consultant at BCG in the PIPE and Global Health practices. Symes is a Fellow of the Actuarial Society of South Africa.
- Where does Matt Symes work?
- Matt Symes is Investor at Delin Ventures.
- Where did Matt Symes go to school?
- Matt Symes studied at Stellenbosch University (BComHons, Actuarial Science); Stellenbosch University (Bcom, Actuarial Science).
Same school
Also attended Stellenbosch University123
Samantha CampbellOperations Manager at 4Di CapitalNesbit WestAdvisor - Fund Compliance at Keen Venture PartnersJohanneke van de Scheur-BaanBestuurslid at NoaberWilmari SmitFund Controller at White Star CapitalVincent CoonInvestor at HV CapitalJurgen Van de VyverPartner at Launchpad Capital
+ 117 more
Shared employers
Also worked at Delin Ventures12
Igor LinshitsFounder at Delin VenturesJonathan HayPartner at Delin VenturesCarol LynchAdvisor at Delin VenturesIskender DirikPartner at Delin VenturesRosie BarnettPrincipal at Delin VenturesOliver HemmingsAnalyst at Delin Ventures
+ 6 more
Also worked at adthera bio2
Also worked at Boston Consulting Group (BCG)1,460
Cristina JunqueiraCo-founder of NubankMassimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 VenturesLuca RossettoOperating Advisor at P101 Ventures
+ 1,454 more
